Dual-mechanism estrogen receptor inhibitors | PNAS
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
Dual-mechanism estrogen receptor inhibitors | PNAS
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
New insights into acquired endocrine resistance of breast cancer
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
Dual-mechanism estrogen receptor inhibitors | PNAS
EREs).
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
